Apparently, both companies have stated in a recent WSJ article that they have put forth a planned “initiative includ[ing] two studies to test the anticlotting agent in patients with acute coronary syndrome, a condition marked by unstable chest pain that often leads to a heart attack and accounts for 1.1 million hospital admissions annually in the U.S.”
Additionally, the companies also plan to try and expand Xarelto for “two diseases being studied are stroke caused by a clot of unknown origin and peripheral artery disease, the accumulation of fatty deposits that can obstruct blood flow in the legs. Together with eight other Xarelto studies the companies have launched since March 2013, the findings could lead to a doubling to at least 12 as the number of approved indications for the drug.”
Xarelto, manufactured by Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, has been widely prescribed. But, there may be some problems that may be associated with the use of Xarelto (Rivaroxaban). These problems may include:
- gastrointestinal and cerebral hemorrhaging or bleeding
- deep vein thrombosis
- kidney injuries
- internal bleeding
- stomach ulcers
- heart attack
- ischemic stroke
- thrombotic thrombocytopenic purpora (TTP)
- intracranial bleeding
- and death.
And, as posted earlier, Xarelto lawsuits are on the rise. If you or your loved one suffered internal bleeding from taking Xarelto, or your loved one died as a result, please do not hesitate to contact the Gooch Law firm concerning your situation. A Xarelto lawyer can review your situation and determine if a Xarelto lawsuit can be filed.
At the Gooch Law Firm, we pride ourselves on providing our clients reliable representation for even the most challenging cases. If you took Xarelto and have been diagnosed with internal bleeding and/or a loved one has died as a result of Xarelto, please contact our office at 1.844.329.5955.
WE ARE HERE TO HELP YOU PROTECT YOUR LEGAL RIGHTS